This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (128)  • Contact me when this article is cited  Related Content  • Related letters  • Related article  • Similar articles in this journal  Topic Collections  • Thrombolysis  • Venous Thromboembolism  • Cardiovascular System  • Alert me on articles by topic  Social Bookmarking   What's this?

Linda Harrison, RN; Joanne McGinnis, RN; Mark Crowther, MD; Jeffrey Ginsberg, MD; Jack Hirsh, MD

Arch Intern Med. 1998;158:2001-2003.

Background  Low-molecular-weight (LMW) heparins are safe and effective for out-of-hospital treatment of acute deep-vein thrombosis (DVT) in a clinical trial setting. We examined the efficacy, safety, and feasibility of home treatment with LMW heparin of consecutive eligible patients with acute DVT in a routine care setting. In addition, we report our experience with patient compliance, acceptance, and satisfaction.

Methods  We performed a prospective cohort study of consecutive patients presenting to 2 thromboembolism clinics in a large Ontario city. Eligible patients were treated with LMW heparin for a minimum of 5 days and with long-term warfarin sodium. Outcomes included the incidences of bleeding and recurrence of DVT and pulmonary embolism and patient satisfaction as determined by a questionnaire.

Results  One hundred thirteen patients with objectively confirmed DVT underwent screening; 89 patients were treated at home with LMW heparin. During the study, 1 patient died of a combination of pulmonary embolism and major bleeding, another patient required admission to the hospital for bleeding, and 5 patients with active malignant disease had recurrent DVT. Of the patients who completed the satisfaction questionnaire, 75 (91%) of 82 were pleased with home treatment; 44 (70%) of 63 felt comfortable self-injecting the LMW heparin; and 71 (92%) of 77 were satisfied with the support and instruction they received during the outpatient treatment.

Conclusions  Outpatient treatment of DVT with LMW heparin is safe, effective, and feasible for most patients and is associated with a high degree of patient satisfaction.

From the Hamilton Health Sciences Corporation, Hamilton, Ontario. Dr Ginsberg is a career investigator of the Heart and Stroke Foundation of Ontario, Toronto. Dr Crowther is a research fellow of the Medical Research Council of Canada, Ottawa, Ontario.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED LETTERS

Outpatient Protocols for Treatment of Venous Thromboembolism Using Low-Molecular-Weight Heparin: To Treat or Not to Treat at Home
Alex C. Spyropoulos, Linda Harrison, and Richard S. Liebowitz
Arch Intern Med. 1999;159(10):1139-1140.
EXTRACT | FULL TEXT  

Weight Watching in Heparin
Tsung O. Cheng
Arch Intern Med. 1999;159(10):1142.
EXTRACT | FULL TEXT  

RELATED ARTICLE

Deep Venous Thrombosis: Thinking Inside Out
Richard S. Liebowitz
Arch Intern Med. 1998;158(18):1964.
EXTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Outpatient treatment and early discharge of symptomatic pulmonary embolism: a systematic review
Squizzato et al.
Eur Respir J 2009;33:1148-1155.
ABSTRACT | FULL TEXT  

Treatment of Venous Thromboembolism in Patients with Cancer
Lee
Am Soc Clin Oncol Ed Book 2009;2009:331-336.
ABSTRACT | FULL TEXT  

Initial management of deep venous thrombosis in the outpatient setting
Groce
Am J Health Syst Pharm 2008;65:866-874.
FULL TEXT  

New Anticoagulants for Treatment of Venous Thromboembolism
Gross and Weitz
Arterioscler. Thromb. Vasc. Bio. 2008;28:380-386.
ABSTRACT | FULL TEXT  

Outpatient-Based Primary and Secondary Thromboprophylaxis With Low-Molecular-Weight Heparin
Spyropoulos
CLIN APPL THROMB HEMOST 2008;14:63-74.
ABSTRACT  

Outpatient treatment of venous thromboembolic disease based in an emergency department
Zed et al.
Am J Health Syst Pharm 2005;62:616-619.
ABSTRACT | FULL TEXT  

Therapeutic Update on the Prevention and Treatment of Venous Thromboembolism
McGuire and Dobesh
Journal of Pharmacy Practice 2004;17:289-307.
ABSTRACT  

Antithrombotic Therapy for Venous Thromboembolic Disease: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy
Buller et al.
Chest 2004;126:401S-428S.
ABSTRACT | FULL TEXT  

Initial Treatment of Venous Thromboembolism
McRae and Ginsberg
Circulation 2004;110:I-3-I-9.
ABSTRACT | FULL TEXT  

New Anticoagulants for Treatment of Venous Thromboembolism
Weitz
Circulation 2004;110:I-19-I-26.
ABSTRACT | FULL TEXT  

Effect of Intravenous Heparin Administration on Duration of Hospitalization
Dunn et al.
Mayo Clin Proc. 2004;79:159-163.
ABSTRACT  

Tinzaparin: Considerations for Use in Clinical Practice
Nutescu et al.
The Annals of Pharmacotherapy 2003;37:1831-1840.
ABSTRACT | FULL TEXT  

Dalteparin Compared with an Oral Anticoagulant for Thromboprophylaxis in Patients with Cancer
Blot et al.
NEJM 2003;349:1385-1387.
FULL TEXT  

Hospital Guidelines for Use of Low-Molecular-Weight Heparins
Nutescu et al.
The Annals of Pharmacotherapy 2003;37:1072-1081.
ABSTRACT | FULL TEXT  

The Incidence of Recurrent Venous Thromboembolism After Treatment With Vitamin K Antagonists in Relation to Time Since First Event: A Meta-analysis
van Dongen et al.
Arch Intern Med 2003;163:1285-1293.
ABSTRACT | FULL TEXT  

Thrombotic Disorders: Diagnosis and Treatment
Schafer et al.
ASH Education Book 2003;2003:520-539.
ABSTRACT | FULL TEXT  

Routine home treatment of deep vein thrombosis
Eikelboom and Baker
BMJ 2001;322:1192-1193.
FULL TEXT  

Clinical Trials That Have Influenced the Treatment of Venous Thromboembolism: A Historical Perspective
Hirsh and Bates
ANN INTERN MED 2001;134:409-417.
ABSTRACT | FULL TEXT  

Clinical Risk Factors and Timing of Recurrent Venous Thromboembolism During the Initial 3 Months of Anticoagulant Therapy
Douketis et al.
Arch Intern Med 2000;160:3431-3436.
ABSTRACT | FULL TEXT  

Outpatient treatment for patients with uncomplicated above knee deep vein thrombosis
Lane and Harrison
Emerg. Med. J. 2000;17:403-404.
FULL TEXT  

Effectiveness and Economic Impact Associated With a Program for Outpatient Management of Acute Deep Vein Thrombosis in a Group Model Health Maintenance Organization
Tillman et al.
Arch Intern Med 2000;160:2926-2932.
ABSTRACT | FULL TEXT  

Clinical Outcome and Cost of Hospital vs Home Treatment of Proximal Deep Vein Thrombosis With a Low-Molecular-Weight Heparin: The Vascular Midi-Pyrenees Study
Boccalon et al.
Arch Intern Med 2000;160:1769-1773.
ABSTRACT | FULL TEXT  

The Safety, Efficacy, and Cost Efficiency of Outpatient Treatment of Acute Deep Venous Thrombosis with Low Molecular Weight Heparin
Wakefield
PERSPECT VASC SURG ENDOVASC THER 2000;13:19-25.
ABSTRACT  

Economic Evaluation of Outpatient Treatment With Low-Molecular-Weight Heparin for Proximal Vein Thrombosis
O'Brien et al.
Arch Intern Med 1999;159:2298-2304.
ABSTRACT | FULL TEXT  

Outpatient Protocols for Treatment of Venous Thromboembolism Using Low-Molecular-Weight Heparin: To Treat or Not to Treat at Home
Spyropoulos et al.
Arch Intern Med 1999;159:1139-1140.
FULL TEXT  

Weight Watching in Heparin
Cheng
Arch Intern Med 1999;159:1142-1142.
FULL TEXT  

Outpatient Treatment for DVT?
JWatch General 1998;1998:6-6.
FULL TEXT  

Deep Venous Thrombosis: Thinking Inside Out
Liebowitz
Arch Intern Med 1998;158:1964-1964.
FULL TEXT